Calmolan Retard

Calmolan Retard contains Pramipexole Dihydrochloride Monohydrate, an oral medication used for managing symptoms of Parkinson's disease and restless legs syndrome. This extended-release formulation is designed for consistent symptom control.

Calmolan Retard is primarily used to alleviate symptoms associated with Parkinson's disease, such as tremors, stiffness, and difficulty moving. It is also prescribed for restless legs syndrome, helping to reduce the urge to move the legs. Pramipexole works by affecting the dopamine levels in the brain, which can improve motor function and reduce discomfort.

Common effects of Calmolan Retard may include dizziness, nausea, and fatigue. Some users might experience hallucinations or sudden sleep episodes. These effects can vary in intensity and duration, depending on individual responses to the medication.

Calmolan Retard should be handled with care, especially by individuals with a history of mental health conditions or heart problems. It is important to follow the prescribed dosage and consult a healthcare provider before making any changes. Avoid driving or operating heavy machinery if you experience drowsiness.

Calmolan Retard may interact with alcohol, certain antidepressants, and other medications that affect dopamine levels. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a professional before combining Calmolan Retard with other treatments.